Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
With
Quintiles IMS
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Group A: Subjects with Severe asthma can be enrolled, when they fulfill the following criteria:
Subjects \>= 18 years
Subjects diagnosed with "severe asthma" defined as asthma that requires high-dose inhaled corticosteroids (ICS) plus Long-Acting Beta2-Agonist (LABA), leukotriene modifier/ theophylline in the last 12 months or continuous/almost continuous treatment with systemic glucocorticosteroids (CS) for \>= 50% of the previous year to maintain control of asthma
Subjects treated with ICS/LABA, with the maximum dose recommended by Specific Product Characteristics (SPC).
Subjects who give voluntary written informed consent after explanation of study´s procedures.
Group B: Subjects with Non-Severe asthma can be enrolled, when they fulfill the following criteria:
Subjects \>= 18 years
Subjects diagnosed with non-severe asthma per GINA Guidelines Classification
Subjects who give voluntary written informed consent after explanation of study´s procedures
You may not be if
Subjects who are not able to complete all the follow-ups of the study with all the study procedures
Clareo Health | Prevalence of Severe Asthma in Spanish Hospitals
